Instrument Inactif

Cours Optimer Pharmaceuticals, Inc.

Actions

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Optimer Pharmaceuticals, Inc. : Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc.	04/10/13
Optimer Pharmaceuticals, Inc. : Today's Research: Inovio Pharmaceuticals Inc., Onyx Pharmaceuticals Inc., Sequenom Inc. and Optimer Pharmaceuticals Inc.	29/08/13
Optimer Pharmaceuticals, Inc. : Laboratory Permits, Pending FDA Approvals, Clinical Study Presentations, and Financial Results Release - Research Report on Illumina, Theravance, Acorda, Synta, and Optimer	12/08/13
Optimer Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Optimer Pharmaceuticals, Inc.	01/08/13
Optimer Pharmaceuticals, Inc. : Optimer Reports Second Quarter 2013 Financial Results	01/08/13

Secteur

	Varia. 1 janv.	Capi.
CSL LIMITED	-3,35%	89,69 Md
SAMSUNG BIOLOGICS CO.,LTD.	+3,95%	41,34 Md
BIOGEN INC.	-10,51%	33,72 Md
UCB	+60,58%	26,11 Md
BIOMARIN PHARMACEUTICAL INC.	-20,09%	14,63 Md
INCYTE CORPORATION	-8,92%	12,84 Md
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11,46%	11,66 Md
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,05%	11,52 Md
SWEDISH ORPHAN BIOVITRUM AB	+5,17%	8,92 Md